DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.) Modification Control Number: oconnels0770 See Attached Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.) Add new contract line items for Pentavalent Bot annual testing. Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force a nd effect. — 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print) 15A. NAME AND TITLE OF SIGNER (Type or print) LXXX X. XXXXXXXXX / CONTRACTING OFFICER Rxxxxx Xxxxxx, President & CEO TEL: 300-000-0000 EMAIL: Lxxx.Xxxxxxxxx@XXX.XXXXX.XXXX.XXX —— — 15B. CONTRACTOR/OFFEROR 16B. UNITED STATES OF AMERICA /s/ Rxxxxx Xxxxxx BY /s/ Lxxx X. Xxxxxxxxx —— 15C. DATE SIGNED —— 16C. DATE SIGNED (Signature of person authorized to sign) 11/12/04 (Signature of Contracting Officer) 03-Nov-2004 —— —— —— — STANDARD FORM 30 (REV. 10-83) EXCEPTION TO SF 30 Prescribed by GSA APPROVED BY OIRM 11-84 30-105-04 FAR (48 CFR) 53.243 SECTION SF 30 BLOCK 14 CONTINUATION PAGE
SECTION A — SOLICITATION/CONTRACT FORM The total cost of this contract was increased by $52,324.00 from $167,199,522.30 to $167,251,846.30. SECTION B — SUPPLIES OR SERVICES AND PRICES CLIN 0004 is added as follows: ITEM NO SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE MAX AMOUNT 0004 1 $ 52,324.00 $ 52,324.00 Pentavalent Botulinum Testing FFP Conduct Pentavalent Botulinum Long-Term Interval Testing for lots PBP003 and PBP0004 using Protocol Numbers LTIT2003-001 and LTIT2003-002 NET AMT $ 52,324.00 Funded Amount $ 0.00 FOB: Destination
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible. Please See attached page. Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.) The purpose of this modification is to provide an additional allotment of funds for continued performance of this contract. This modification also contains a reduction in the firm fixed price of the contract and makes an administrative change to the contract. Accordingly: Except as provided herein, all terms and conditions of the document referenced in Item 9A and 10A, as heretofore changed, remains unchanged and in full force and effect. ________________________________________________________________________________
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.) Modification Control Number: cochrane11310 This bilateral modification to N00033-07-C-5416 adds $35,233,401.79 in FY 11 funding for the charter hire and reimbursable items for the MT EMPIRE STATE PRs N000331322PST1 and N000331302PST2 apply, respectively. This modification also updates the following sections within the contract: C-4.1, Crew List; C-23, Reporting Requirements; G-1, Designation of Principal Contracting Officer; and H-37, Force Protection. Please see attached. Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect. 15A. NAME AND TITLE OF SIGNER (Type or print) Xxxxxx X. Xxxx, CEO 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print) XXX XXXXXXXXX, CONTRACTING OFFICER Tel: 000 000 0000 EMAIL: XXX XXXXXXXXX@XXXX.XX 15B. CONTRACTOR/OFFEROR /s/ Xxxxxx X. Xxxx 15C. DATE SIGNED 16B. UNITED STATES OF AMERICA BY /s/ Xxx Xxxxxxxxx 16C. DATE SIGNED (Signature of person authorized to sign) 11/24/10 (Signature of Contracting Officer) 24 Nov 2010 EXCEPTION TO SF 30 30-105-04 STANDARD FORM 30 (REV. 10-83) APPROVED BY OIRM 11-84 Prescribed by GSA FAR (48 CFR) 53.243 SECTION SF 30 BLOCK 14 CONTINUATION PAGE NOO0331322P5Tl MT EMPIRE STATE 0001 Charter Hire 121186 010100 2521K $ 26,714,000.00 ($74,000.00 daily charter hire x 361 days). NOO0331302P5T2 MT EMPIRE STATE 0002 Reimbursables 121186 010100 2522K, 26052 $ 8,519,401. 79
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.) The purpose of this modification is to extend the performance period of this contract for six months at no additional cost to the government, and to approve a revised scope of work dated, February 2005 Entitled: “Prevention of Anthrax Infection by CPG Oligodeoxynucleotides”, pages 1 through 15.
1. Amend Section F.1, Period of Performance: FROM: 6 December 2002 – 28 February 2005 TO: 6 December 2002 – 28 August 2005.
2. The revised scope of work as proposed by Xxxxx Pharmaceuticals has been reviewed and approved by the Technical Monitor on 16 February 2005 and will become effective upon the date of this modification. See attachment A.
3. All else remains the same. Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect. 00X.XXXX AND TITLE OF SIGNER (Type or print) 00X.XXXX AND TITLE OF CONTRACTING OFFICER (Type or print) XXXXX X. XXXXX / GRANTS/CONTRACTING OFFICER TEL: (000) 000-0000 EMAIL: xxxxxx@xxx-xxxx0.xxxx.xxx 00X.XXXXXXXXXX/OFFEROR 00X.XXXX SIGNED 16B.UNITED STATES OF AMERICA 00X.XXXX SIGNED BY /s/ Xxxxx X. Xxxxx 28-Feb-2005 (Signature of person authorized to sign) (Signature of Contracting Officer) EXCEPTION TO SF 30 APPROVED BY OIRM 11-84 30-105-04 STANDARD FORM 30 (Rev. 10-83) Prescribed by GSA FAR (48 CFR) 53.243 Protection from Anthrax Infection Using Program Director: Xxxxx CpG Oligodeoxynucleotides Xxxxx Pharmaceutical Group The [******************] vaccine against anthrax [*****************] has been demonstrated to be safe and effective in its approved regimen of [*] injections over [**] months. However, there is great interest in further improving the safety and efficacy of the vaccine by reducing the number of doses that need to be given in order to achieve protective antibody levels against the anthrax toxin proteins. Human and animal data suggest that combining a Xxxxx TLR9 agonist with [***] would offer the following advantages compared to the current vaccine: i) much faster seroconversion with induction of protective antibody levels in most subjects within [*] weeks; ii) reduced number of [***] doses required, to no more than [***********************] dose vaccination; iii) generation of higher affinity antibodies targeted against a broader range of epitopes to give improved protection against mutant strains; and i...
DESCRIPTION OF AMENDMENT. Signature: Insert a reference to the item in the Agreement (name of document and name of clause) that changes and enter the change (enter new text).. For the Customer: For the Vendor:
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation / contract subject matter where feasible.) | Except as provided herein, all terms and conditions of the document referenced in item 9A or 10A, as heretofore j changed remains unchanged and in full force and effect. 15A. NAME AND TITLE OF SIGNER (Type or print) 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print) hfbbY $$$n k$$ f' Xxxxxx Xxxxxx-Xxxxxx XXXxX X. MAGI [, CpfrRACTING OFFICER (Sindature of' person authorized to sign) Y|7 f (SidnaturddP'Contractibe Of ficer) , . [ N 0000-00-000 8070 30-105 ' / ' P VIOUS EDITION UNUSABLE / 9603010221 960219 PDR CONTR NRC-04-94-050 PDR SIANDARD FORM 30 (REV.10 83) Prescribed by GSA FAR (48 CFR) 53.243 [ _ _ _ - _ _ _ _ _ _ _ NRC-04-94-050 Modification No. 2 The purpose of this modification is to: (1) incr v3e the contract ceiling by $738.561 from $1.557.344 to $2.295,905 and (2) exercise the first year option period. Accordingly, the contract is hereby modified as follows:
1.) SectionB.3,CONSIDERATIONANDOBLIGATION--TASKORdERS.paragrapha.
sentence 1 is revised as follows:
(a) The total estimated amount of this contract (ceiling) I for the products / services ordered delivered, and accepted under this contract is 12.295.905.
2.) Section F.6, " DURATION OF CONTRACT PERIOD" (MAR 1987) ALTERNATE IV (JUN 1988) is modified as follows: The ordering period for this contract shall commence on January 1. 1994 and will expire on December 31, 1996. Any orders issued during this period shall be co',ipleted within the time specified in the order, unless otherwise specified herein. (See 52.216-18 - Ordering) The term of this contract may be extended at the option of the Government for two one-year option periods.
DESCRIPTION OF AMENDMENT. MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.) The purpose of this modification is to make changes to the company's address, CAGE code, DUNS number, and assigned DCMA office of the subject contract. See page 2 for details. Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.
